UNM's Colonial Life is gaining momentum through sales growth, favorable claims, higher investment income and strong profitability.
Unum (UNM) reported earnings 30 days ago. What's next for the stock?
UNM's new $1 billion buyback authorization reinforces shareholder returns, backed by strong capital and recurring repurchases.
Unum Group NYSE: UNM reported second-quarter after-tax adjusted operating earnings per share of $2.16, up 4.9% from a year earlier, while year-to-date adjusted operating EPS rose 7.5%. The insurer reaffirmed its full-year adjusted operating EPS outlook of $8.60 to $8.90 despite pressure in paid family and medical leave business in the United States and group income protection in the United Kingdom.
Unum's Q2 results benefits from premium growth and strong core business performance, though lower investment income and higher costs weigh on earnings.
While the top- and bottom-line numbers for Unum (UNM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Unum (UNM) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $2.14 per share. This compares to earnings of $2.07 per share a year ago.
UNM's Q2 results are expected to benefit from favorable persistency, stronger sales and growth across its key operating segments.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Unum (UNM) have what it takes?
Unum (UNM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unum Group's premium growth, technology investments and capital returns support long-term growth, though pricing pressure and higher expenses remain risks.
Unum Group NYSE: UNM said it has agreed to reinsure an additional portion of its long-term care insurance liabilities, marking the company's third major external reinsurance transaction and its second involving long-term care.